I-
A Randomized, Active- Controlled, Single- Blind, Two- Sequence Parallel Clinical Trial to Evaluate the Efficacy of Diacure- Z® (Linalool 0.25 mL Enteric Coated Tablets) in Treatment of Type II Diabetes Mellitus.
Sponsor: Diabex and Al-Hanaa An-Nader Co. in Association with Delass Natural Products Co.- Jordan
Study Code: CLIN001/06
II- Two- Stage Study to Evaluate of the Effect of Tonigrow® on Oral Iron Absorption
Stage I: A Randomized, Single- Blind, Placebo- Controlled Two- Sequence Crossover Bioavailability Study to Compare Oral Absorption of Iron from Oral Iron Supplement versus Absorption of Iron from Oral Iron Supplement with Tonigrow® in Healthy Participants.
Stage II: A Randomized, Single- Blind, Placebo- Controlled, Parallel Clinical Trial to Evaluate the Efficacy of Tonigrow® in Increasing Oral Absorption of Iron Salts in Patients With Iron Deficiency Anemia
Sponsor: Delass Natural Products Co.- Jordan
Study Code: CLIN002/06
III- A prospective, multicenter, investigator-blinded, randomized, comparative study to estimate the safety, tolerability and efficacy of NXL104/Ceftazidime vs. Imipenem Cilastatin followed by appropriate oral therapy in the treatment of complicated urinary tract infections in hospitalized adults.
Sponsor: Novexel